Published in Am J Trop Med Hyg on September 01, 1996
Taenia solium cysticercosis. Lancet (2003) 5.89
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry (2000) 2.28
Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63
Prevalence and risk factors associated with human Taenia solium infections in Mbozi District, Mbeya Region, Tanzania. PLoS Negl Trop Dis (2013) 1.06
Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health (2012) 1.03
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World. PLoS Negl Trop Dis (2015) 1.00
A cross-sectional study of Taenia solium in a multiple taeniid-endemic region reveals competition may be protective. Am J Trop Med Hyg (2012) 0.97
Comparative evaluation of purified Taenia solium glycoproteins and crude metacestode extracts by immunoblotting for the serodiagnosis of human T. solium cysticercosis. Clin Diagn Lab Immunol (1997) 0.96
Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis (2013) 0.91
Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis. Curr Infect Dis Rep (1999) 0.84
Prevalence of Neurocysticercosis in People with Epilepsy in the Eastern Province of Zambia. PLoS Negl Trop Dis (2015) 0.84
A seroepidemiological survey of Taenia solium cysticercosis in Nabo, Guangxi Zhuang Autonomous Region, China. Korean J Parasitol (2005) 0.81
The hamster model for identification of specific antigens of Taenia solium tapeworms. J Biomed Biotechnol (2011) 0.77
Human Glutathione S-Transferase Enzyme Gene Polymorphisms and Their Association With Neurocysticercosis. Mol Neurobiol (2016) 0.77
Geospatial and age-related patterns of Taenia solium taeniasis in the rural health zone of Kimpese, Democratic Republic of Congo. Acta Trop (2016) 0.75
Parasitic infections and maternal anaemia among expectant mothers in the Dangme East District of Ghana. BMC Res Notes (2017) 0.75
High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru. PLoS Negl Trop Dis (2016) 0.75
The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review. Infect Dis Poverty (2017) 0.75
Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin. Parasit Vectors (2017) 0.75
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun (1998) 3.92
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40
Visualization of gene expression in living adult Drosophila. Science (1996) 2.92
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol (1998) 2.60
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55
Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol (1999) 2.17
Biological activities of Brucella abortus lipopolysaccharides. Infect Immun (1981) 2.13
Nucleotide sequence of the 16S rRNA from Brucella abortus. Nucleic Acids Res (1989) 2.05
A molecular phylogeny of the genus Echinococcus inferred from complete mitochondrial genomes. Parasitology (2006) 2.05
Interactions between landscape changes and host communities can regulate Echinococcus multilocularis transmission. Parasitology (2003) 1.98
Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides. Infect Immun (1981) 1.96
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82
The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A (2002) 1.77
Immunodiagnosis of taeniasis by coproantigen detection. Parasitology (1990) 1.75
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74
[Validity of the protocol for evaluating the inappropriate use of hospitalization]. Med Clin (Barc) (1996) 1.70
Coproantigen detection for immunodiagnosis of echinococcosis and taeniasis in dogs and humans. Parasitology (1992) 1.66
Monochromatic aberrations and point-spread functions of the human eye across the visual field. J Opt Soc Am A Opt Image Sci Vis (1998) 1.56
Detection, screening and community epidemiology of taeniid cestode zoonoses: cystic echinococcosis, alveolar echinococcosis and neurocysticercosis. Adv Parasitol (1996) 1.55
Diagnosis and treatment of human hydatidosis. Br J Clin Pharmacol (1993) 1.51
Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology (1999) 1.51
Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis. J Clin Microbiol (1980) 1.50
Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J Bacteriol (1996) 1.49
Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect (2006) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology (1997) 1.48
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47
Human cystic echinococcosis in nomads of south-west Islamic Republic of Iran. East Mediterr Health J (2007) 1.46
Survey of parasite infections not endemic to the United Kingdom in quarantined animals. Vet Rec (2001) 1.45
Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun (1984) 1.45
A new species of Leishmania parasite from the Venezuelan Andes region. Trans R Soc Trop Med Hyg (1979) 1.43
Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. Am J Trop Med Hyg (1994) 1.43
The immune spectrum in patients with pulmonary tuberculosis. Am Rev Respir Dis (1981) 1.43
Characterization of Brucella abortus soluble antigen employed in immunoassay. J Clin Microbiol (1980) 1.43
[Laparoscopic cholecystectomy without pneumoperitoneum. A review of 150 cases]. Acta Gastroenterol Latinoam (2000) 1.39
[Caroli disease: a case report and review of literature]. Acta Gastroenterol Latinoam (1998) 1.39
Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38
Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology (2008) 1.38
Hydatid disease. Vet Rec (1995) 1.38
Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg (1999) 1.36
Half-life of the plasma membrane ATPase and its activating system in resting yeast cells. Biochim Biophys Acta (1991) 1.33
Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J Immunol (1979) 1.32
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
An extensive ultrasound and serologic study to investigate the prevalence of human cystic echinococcosis in northern Libya. Am J Trop Med Hyg (1999) 1.26
The detection of circulating antigen in human hydatid disease. Ann Trop Med Parasitol (1984) 1.25
Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol (2000) 1.24
Cystic echinococcosis in semi-nomadic pastoral communities in north-west China. Trans R Soc Trop Med Hyg (2001) 1.23
Human cystic echinococcosis in a Uruguayan community: a sonographic, serologic, and epidemiologic study. Am J Trop Med Hyg (1998) 1.23
Enzyme immunoassays for serological diagnosis of bovine brucellosis: A trial in Latin America. Clin Diagn Lab Immunol (1998) 1.23
Prevalence of zoonotic important parasites in the red fox (Vulpes vulpes) in Great Britain. Vet Parasitol (2003) 1.22
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg (1998) 1.20
Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun (1992) 1.20
Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1996) 1.20
Genotyping of human cystic echinococcosis in Xinjiang, PR China. Parasitology (2006) 1.17
Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17
Entanglement of two qubits mediated by one-dimensional plasmonic waveguides. Phys Rev Lett (2011) 1.15
Dipstick dot ELISA for the detection of Taenia coproantigens in humans. Parasitology (1993) 1.13
Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol (1999) 1.12
Epidemiology of alveolar echinococcosis in Xinjiang Uygur autonomous region, China: a preliminary analysis. Ann Trop Med Parasitol (2000) 1.11
Brucella lipopolysaccharides and polysaccharides. Ann Inst Pasteur Microbiol (1987) 1.11
A pilot, serological survey for cystic echinococcosis in north-western Mongolia. Ann Trop Med Parasitol (1997) 1.11
Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect (2000) 1.11
Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun (1984) 1.10
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09
Hydatid disease: research and control in Turkana. II. The role of immunological techniques for the diagnosis of hydatid disease. Trans R Soc Trop Med Hyg (1986) 1.08
Rabies control and hydatid disease. Vet Rec (1998) 1.08
IgG1 and IgG4 serum antibody responses in asymptomatic and clinically expressed cystic echinococcosis patients. Acta Trop (1997) 1.08
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Med Clin (Barc) (1998) 1.07
Polyparasitism on the Kenya coast. 1. Prevalence, and association between parasitic infections. Ann Trop Med Parasitol (1992) 1.07
Role of dog behaviour and environmental fecal contamination in transmission of Echinococcus multilocularis in Tibetan communities. Parasitology (2011) 1.06
Echinococcus granulosus coproantigens: chromatographic fractionation and characterization. Parasitology (2004) 1.06
Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J Immunol (1999) 1.05
The depth-of-field of the human eye from objective and subjective measurements. Vision Res (1999) 1.05
Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay. Parasite Immunol (1986) 1.05
Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol (2002) 1.05
Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry (2011) 1.04
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol (2005) 1.03
Analysis of immunoglobulin G subclass in the serum antibody responses of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans R Soc Trop Med Hyg (1996) 1.02
Epidemiology of intestinal taeniasis in four, rural, Guatemalan communities. Ann Trop Med Parasitol (1996) 1.01
Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol (1995) 1.01
Diagnosis of Echinococcus granulosus infection in dogs. Vet Rec (1992) 1.01
IgG-subclass antibody responses and the natural history of hepatic cystic echinococcosis in asymptomatic patients. Ann Trop Med Parasitol (2000) 1.01
An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol (2001) 1.01